Related Experiment Video

Updated: May 27, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.4K

Utilization of Doxycycline Postexposure Prophylaxis at a Midwestern United States HIV/PrEP Clinic

Shawnalyn W Sunagawa1, Gabriel Codling1, Elizabeth Lyden2

  • 1College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Open Forum Infectious Diseases
|February 18, 2025
PubMed

Keywords:
Chlamydia trachomatisNeisseria gonorrhoeaeTreponema pallidumdoxycyclinepostexposure prophylaxissexually transmitted infections

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.4K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Related Concept Videos

Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K